Coronavirus and Brain: Diagnosing and Treating COVID-19’s Neurological Effects
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (18 November 2022) | Viewed by 7936
Special Issue Editors
2. Department of Medicine (Neurology) John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
3. Graduate Faculty, Clinical & Translational Research, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
Interests: neurology; neuroscience; neuroimmunology; COVID-19
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine (Neurology) John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
3. Graduate Faculty, Clinical & Translational Research, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
Interests: neurology; neuroscience; neuroimmunology; COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurological complications of Coronavirus disease 2019 (COVID-19) were first recognized during the initial outbreak in Wuhan, China. Since then, a great deal of information has been shared about the neurological aspects of COVID-19, including acute neurological manifestations, such as encephalopathy, cerebrovascular diseases, neuromuscular diseases, and smell and taste disorders. Long-term persistent complications, such as the cognitive effects of COVID-19, are equally important. Other issues include management of immunosuppressive therapy and neurological side effects associated with COVID-19 treatments and vaccines. A better understanding of the neuropathogenesis, including neuronal and immune dysfunction, renin–angiotensin system dysfunction and viral invasion of the nervous system, will enhance our understanding of these clinicopathologic conditions.
We dedicate this Special Issue of “Coronavirus and Brain: Diagnosing and Treating COVID-19’s Neurological Effects” as a “Call for Action”, and invite the medical and scientific community to join us in raising awareness promoting early and accurate diagnosis. This will result in more favorable treatments and outcomes for the growing number of patients worldwide who are affected by COVID-19.
Prof. Dr. Jason Viereck
Prof. Dr. Kore Kai Liow
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
